Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

B. Riley Securities Initiates Coverage On Abacus Life with Buy Rating, Announces Price Target of $16

Author: Benzinga Newsdesk | May 31, 2024 09:06am
B. Riley Securities analyst Matt Howlett initiates coverage on Abacus Life (NASDAQ:ABL) with a Buy rating and announces Price Target of $16.

Posted In: ABL